Bromberg, Jacqueline
Memorial Hospital Research Laboratories
Physician-scientist Jacqueline Bromberg focues on aberrantly activated Stat3 and the mechanisms of Stat3-mediated
transformation.
Cheng, Emily H.
Physician-scientist Emily Cheng focuses on the molecular mechanisms of cell death and their implications in tumorigenesis and cancer
therapy.
Chiosis, Gabriela
Chemical biologist Gabriela Chiosis studies the pharmacological modulation of molecular chaperones in transformed systems.
Clarkson, Bayard
Molecular Pharmacology & Chemistry Program
Chemical biologist Bayard Clarkson focuses on the development of targeted therapies aimed at cancer stem cells.
Fong, Yuman
Memorial Hospital Research Laboratories
Physician-scientist Yuman Fong develops herpes-based oncolytic
viral therapies for the treatment of
malignancy.
Giancotti, Filippo
Cell Biology Program
Cell biologist Filippo Giancotti investigates signaling by cell adhesion receptors, neoplastic transformation, and
metastatic dissemination.
Grimm, Jan
Molecular Pharmacology & Chemistry Program
Radiologist Jan Grimm develops novel activatable molecular
imaging approaches for improved detection and monitoring of
prostate and other cancers.
Haynes, Cole
Cell Biology Program
Cell biologist Cole Haynes focuses on the molecular mechanisms of mitochondrial function during development, aging, and cancer cell growth.
Li, Yueming
Molecular Pharmacology & Chemistry Program
Biochemist Yueming Li studies function and regulation of transmembrane proteases and development of novel protease-based cancer therapies.
Lowe, Scott W.
Chair, Geoffrey Beene Cancer Research Center
Cancer Biology & Genetics Program
Biologist Scott Lowe investigates tumor-suppressor gene networks that control
apoptosis and senescence.
Marks, Paul A.
Cell Biology Program
Cell biologist Paul Marks focuses on the study of agents that selectively target histone deacetylases and cause transformed cell growth arrest, terminal differentiation, apoptosis, and/or cell death.
Petrini, John
Molecular Biology Program
Molecular biologist John Petrini investigates the repair of chromosomal breaks and the activation of the DNA-damage-induced cell-cycle checkpoints.
Scheinberg, David A.
Chair, Molecular Pharmacology & Chemistry Program, SKI
Molecular Pharmacology & Chemistry Program
Molecular Pharmacology and Chemistry Program Chair David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.
Schwartz, Gary
Memorial Hospital Research Laboratories
Physician-scientist Gary Schwartz focuses on the identification of cell-cycle inhibitors that promote chemotherapy-induced apoptosis and their use in cancer therapy.
Thompson, Craig B.
President and CEO, Memorial Sloan-Kettering Cancer Center
Cancer Biology & Genetics Program
Memorial Sloan-Kettering President Craig Thompson studies molecular signaling pathways that regulate
nutrient uptake and the role these pathways play in the regulation of cell growth and survival.
Wendel, Hans-Guido
Cancer Biology & Genetics Program
Cancer biologist Hans-Guido Wendel focuses on modeling the genetics of tumor initiation, progression, and treatment response
in vivo.